Open Government Portal
This document is intended to clarify how SaMD fits into Health Canada's regulatory framework for medical devices, based on current …
Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human …
Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human …
The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis …
The purpose of this Notice of Amendment is to notify that Health Canada has added phytocannabinoids to the Human and …
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or …
The purpose of this Notice of Amendment is to notify that Health Canada has removed tramadol from the Prescription Drug …
Health Canada is issuing this notice to clinical trial sponsors to clarify the approach to clinical research with psilocybin. Health …
Health Canada is aware of the growing interest in the use of psilocybin, including psilocybin that occurs naturally in certain …
Health Canada is aware of the growing interest in the use of psilocybin, including psilocybin that occurs naturally in certain …